Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1984 Mar;43(3):966–972. doi: 10.1128/iai.43.3.966-972.1984

Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody.

D L Brawner, J E Cutler
PMCID: PMC264279  PMID: 6199308

Abstract

The expression of a surface immunodeterminant of Candida albicans was investigated with an agglutinating immunoglobulin M monoclonal antibody. The 96 strains of C. albicans tested, of which 76% were recent clinical isolates, were capable of expressing the antigen. The antigen was also produced by strains of Candida tropicalis and Torulopsis glabrata, but not by other yeast species. Expression of the surface immunodeterminant in C. albicans varied as a function of growth as indicated by agglutinin reactions and indirect immunofluorescence tests. When yeast cells were tested with the agglutinin, three patterns of reactivity were observed. In general, cells in the early logarithmic phase were less reactive than cells in the mid-logarithmic phase. Antigen expression, as determined by agglutinin reactivity, was also influenced by the nutritional composition of the growth medium, and in general, cells from broth cultures were usually more reactive than cells grown on solid media. The antigen was solubilized from the cell surface of C. albicans by hot 1 M NaCl. These water-soluble extracts were capable of binding antibody, and a single precipitin band formed when soluble antigen was reacted with the monoclonal antibody in an Ouchterlony double-diffusion test. Whole cell preparations and hot NaCl extracts from yeast strains which did not agglutinate when mixed with the antibody also did not absorb the agglutinin from solution. These data indicate that the expression of surface antigens on C. albicans is a dynamic process which may be influenced by a number of environmental factors. The use of monoclonal antibodies may allow characterization of surface antigens presented to the host during candidiasis.

Full text

PDF
966

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown L. A., Chaffin W. L. Differential expression of cytoplasmic proteins during yeast bud and germ tube formation in Candida albicans. Can J Microbiol. 1981 Jun;27(6):580–585. doi: 10.1139/m81-088. [DOI] [PubMed] [Google Scholar]
  2. Buckley R. H., Lucas Z. J., Hattler B. G., Jr, Zmijewski C. M., Amos D. B. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol. 1968 Feb;3(2):153–169. [PMC free article] [PubMed] [Google Scholar]
  3. Chesebro B., Wehrly K., Cloyd M., Britt W., Portis J., Collins J., Nishio J. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens. Virology. 1981 Jul 15;112(1):131–144. doi: 10.1016/0042-6822(81)90619-x. [DOI] [PubMed] [Google Scholar]
  4. Cleveland W. W., Fogel B. J., Brown W. T., Kay H. E. Foetal thymic transplant in a case of Digeorge's syndrome. Lancet. 1968 Dec 7;2(7580):1211–1214. doi: 10.1016/s0140-6736(68)91694-2. [DOI] [PubMed] [Google Scholar]
  5. Cutler J. E., Poor A. H. Effect of mouse phagocytes on Candida albicans in in vivo chambers. Infect Immun. 1981 Mar;31(3):1110–1116. doi: 10.1128/iai.31.3.1110-1116.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fukazawa Y., Shinoda T., Tsuchiya T. Response and specificity of antibodies for Candida albicans. J Bacteriol. 1968 Mar;95(3):754–763. doi: 10.1128/jb.95.3.754-763.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greenfield R. A., Jones J. M. Comparison of cytoplasmic extracts of eight Candida species and Saccharomyces cerevisiae. Infect Immun. 1982 Mar;35(3):1157–1161. doi: 10.1128/iai.35.3.1157-1161.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Guinet R. M., Gabriel S. M. Candida albicans group A-specific soluble antigens demonstrated by quantitative immunoelectrophoresis. Infect Immun. 1980 Sep;29(3):853–858. doi: 10.1128/iai.29.3.853-858.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HASENCLEVER H. F., MITCHELL W. O. Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J Bacteriol. 1961 Oct;82:570–573. doi: 10.1128/jb.82.4.570-573.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HASENCLEVER H. F., MITCHELL W. O. IMMUNOCHEMICAL STUDIES ON POLYSACCHARIDES OF YEASTS. J Immunol. 1964 Nov;93:763–771. [PubMed] [Google Scholar]
  11. Hector R. F., Domer J. E., Carrow E. W. Immune responses to Candida albicans in genetically distinct mice. Infect Immun. 1982 Dec;38(3):1020–1028. doi: 10.1128/iai.38.3.1020-1028.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hiatt W. R., Inderlied C. B., Sypherd P. S. Differential synthesis of polypeptides during morphogenesis of Mucor. J Bacteriol. 1980 Mar;141(3):1350–1359. doi: 10.1128/jb.141.3.1350-1359.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  14. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  15. Kirkpatrick C. H., Rich R. R., Smith T. K. Effect of transfer factor on lymphocyte function in anergic patients. J Clin Invest. 1972 Nov;51(11):2948–2958. doi: 10.1172/JCI107119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. LOURIA D. B., BRAYTON R. G. BEHAVIOR OF CANDIDA CELLS WITHIN LEUKOCYTES. Proc Soc Exp Biol Med. 1964 Jan;115:93–98. doi: 10.3181/00379727-115-28840. [DOI] [PubMed] [Google Scholar]
  17. Lehrer R. I. Functional aspects of a second mechanism of candidacidal activity by human neutrophils. J Clin Invest. 1972 Oct;51(10):2566–2572. doi: 10.1172/JCI107073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Manning M., Mitchell T. G. Analysis of cytoplasmic antigens of the yeast and mycelial phases of Candida albicans by two-dimensional electrophoresis. Infect Immun. 1980 Nov;30(2):484–495. doi: 10.1128/iai.30.2.484-495.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Montrocher R. Significance of immunoprecipitation in yeast taxonomy: antigenic analyses of some species within the genus Candida. Cell Mol Biol Incl Cyto Enzymol. 1980;26(3):293–302. [PubMed] [Google Scholar]
  20. Morelli R., Rosenberg L. T. Role of complement during experimental Candida infection in mice. Infect Immun. 1971 Apr;3(4):521–523. doi: 10.1128/iai.3.4.521-523.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Moser S. A., Domer J. E. Effects of cyclophosphamide on murine candidiasis. Infect Immun. 1980 Feb;27(2):376–386. doi: 10.1128/iai.27.2.376-386.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mourad S., Friedman L. Passive immunization of mice against Candida albicans. Sabouraudia. 1968 Feb;6(2):103–105. [PubMed] [Google Scholar]
  23. Müller H. L., Kirchhoff G. Serologische Typen von Candida albicans. Zentralbl Bakteriol Orig. 1969 May;210(1):114–121. [PubMed] [Google Scholar]
  24. Odds F. C., Evans E. G., Taylor M. A., Wales J. K. Prevalence of pathogenic yeasts and humoral antibodies to candida in diabetic patients. J Clin Pathol. 1978 Sep;31(9):840–844. doi: 10.1136/jcp.31.9.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  26. Pearsall N. N., Adams B. L., Bunni R. Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J Immunol. 1978 Apr;120(4):1176–1180. [PubMed] [Google Scholar]
  27. Peterson E. M., Calderone R. A. Growth inhibition of Candida albicans by rabbit alveolar macrophages. Infect Immun. 1977 Mar;15(3):910–915. doi: 10.1128/iai.15.3.910-915.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Poulain D., Tronchin G., Lefebvre B., Husson M. O. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection. Sabouraudia. 1982 Sep;20(3):173–177. [PubMed] [Google Scholar]
  29. Poulain D., Tronchin G., Vernes A., Popeye R., Biguet J. Antigenic variations of Candida albicans in vivo and in vitro--relationships between P antigens and serotypes. Sabouraudia. 1983 Jun;21(2):99–112. [PubMed] [Google Scholar]
  30. Rinaldi M. G. Use of potato flakes agar in clinical mycology. J Clin Microbiol. 1982 Jun;15(6):1159–1160. doi: 10.1128/jcm.15.6.1159-1160.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. SUMMERS D. F., GROLLMAN A. P., HASENCLEVER H. F. POLYSACCHARIDE ANTIGENS OF CANDIDA CELL WALL. J Immunol. 1964 Mar;92:491–499. [PubMed] [Google Scholar]
  32. Schulking M. L., Adler W. H., 3rd, Altemeier W. A., 3rd, Ayoub E. M. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol. 1972 Apr;3(4):606–615. doi: 10.1016/0008-8749(72)90122-0. [DOI] [PubMed] [Google Scholar]
  33. Segal E., Vardinon N., Schwartz J., Eylan E. Antigenic relationships between Candida albicans and various yeasts as reflected by immunoglobulin-class specificity. Pathol Microbiol (Basel) 1975;42(1):49–58. doi: 10.1159/000162721. [DOI] [PubMed] [Google Scholar]
  34. Suzuki M., Fukazawa Y. Immunochemical characterization of Candida albicans cell wall antigens: specific determinant of Candida albicans serotype A mannan. Microbiol Immunol. 1982;26(5):387–402. doi: 10.1111/j.1348-0421.1982.tb00189.x. [DOI] [PubMed] [Google Scholar]
  35. Sweet C. E., Kaufman L. Application of agglutinins for the rapid and accurate identification of medically important Candida species. Appl Microbiol. 1970 May;19(5):830–836. doi: 10.1128/am.19.5.830-836.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. TSUCHIYA T., FUKAZAWA Y., KAWAKITA S. A method for the rapid identification of the genus Candida. Mycopathol Mycol Appl. 1959 Mar 31;10(3):191–206. doi: 10.1007/BF02053014. [DOI] [PubMed] [Google Scholar]
  37. Taguchi M., Tsukiji M., Tsuchiya T. Rapid identification of yeasts by serological methods: a combined serological and biological method. Sabouraudia. 1979 Sep;17(3):185–191. doi: 10.1080/00362177985380271. [DOI] [PubMed] [Google Scholar]
  38. Takeda N., Okubo Y., Ichikawa T., Suzuki S. Cross-reaction between the mycelial galactomannas of three Hormodendrum strains and the mannans of two Candida albicans strains of different serotypes, A and B. Infect Immun. 1979 Jan;23(1):146–149. doi: 10.1128/iai.23.1.146-149.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tsuchiya T., Fukazawa Y., Taguchi M., Nakase T., Shinoda T. Serologic aspects on yeast classification. Mycopathol Mycol Appl. 1974 Aug 30;53(1):77–91. doi: 10.1007/BF02127199. [DOI] [PubMed] [Google Scholar]
  40. Valdimarsson H., Higgs J. M., Wells R. S., Yamamura M., Hobbs J. R., Holt P. J. Immune abnormalities associated with chronic mucocutaneous candidiasis. Cell Immunol. 1973 Mar;6(3):348–361. doi: 10.1016/0008-8749(73)90035-x. [DOI] [PubMed] [Google Scholar]
  41. Winterrowd G. E., Cutler J. E. Candida albicans-induced agglutinin and immunoglobulin E responses in mice. Infect Immun. 1983 Jul;41(1):33–38. doi: 10.1128/iai.41.1.33-38.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES